Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: A randomised, comparator-controlled, phase 2 trial

Related articles

1. Safety and Immunogenicity of a VLP Poliovirus Vaccine: A Phase 1 Trial

   This article has 15 authors:

   1. Christina C. Chang
   2. Ruijie Wang
   3. Sumeyya Ahmed
   4. Yujia Chen
   5. Basit Jafri
   6. Camilla Lucy Smith
   7. Bernardo A. Mainou
   8. Lina Wang
   9. Xiaoyuan Zhao
   10. Meixu Yan
   11. Haitao Huang
   12. Qiaoling Yan
   13. Luis Barreto
   14. Jinbo Gou
   15. Tao Zhu

2. Biomarkers of protection against controlled human SARS-CoV-2 Delta variant breakthrough infection

   This article has 40 authors:

   1. Anika Singanayagam
   2. Helen R. Wagstaffe
   3. Lydia Slater
   4. Polly Fox-Sheehan
   5. Meng-San Wu
   6. Andrew Mawer
   7. Hannah Preston-Jones
   8. Orlagh Daly
   9. Jen Mae Low
   10. Raquel Lopez Ramon
   11. Eileen Hughes
   12. Jie Zhou
   13. Anjna Badhan
   14. Jon Guy
   15. Stephanie A. Harris
   16. Samuel P. Smith
   17. Melissa Govender
   18. Stephen M. Laidlaw
   19. Tom Tipton
   20. Iman Satti
   21. Merenienla Yaden
   22. Stephanie Ascough
   23. Ksenia Sukhova
   24. Maya Moshe
   25. Joanne McKenzie
   26. Henna Siddiqui
   27. Alberta Ateere
   28. Beatrice Nassanga
   29. Freya Stiff
   30. David S. Khoury
   31. Arnold Reynaldi
   32. Miles P. Davenport
   33. Miles Carroll
   34. Ryan S. Thwaites
   35. Graham P. Taylor
   36. Wendy Barclay
   37. Margherita Bracchi
   38. Helen McShane
   39. Christopher Chiu
   40. the COVHIC002 study team

3. Comparative immunogenicity of several inactivated influenza vaccines among healthcare workers in Hong Kong

   This article has 9 authors:

   1. Wey Wen Lim
   2. Lisa Touyon
   3. Loretta Mak
   4. Samuel M. S. Cheng
   5. Yiu Chung Lau
   6. Dennis K. M. Ip
   7. Malik Peiris
   8. Benjamin J. Cowling
   9. Sook-San Wong